Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer EL Rosenthal, JM Warram, E De Boer, TK Chung, ML Korb, ... Clinical Cancer Research 21 (16), 3658-3666, 2015 | 453 | 2015 |
Beyond the margins: real-time detection of cancer using targeted fluorophores RR Zhang, AB Schroeder, JJ Grudzinski, EL Rosenthal, JM Warram, ... Nature reviews Clinical oncology 14 (6), 347-364, 2017 | 422 | 2017 |
Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence RW Gao, NT Teraphongphom, NS van den Berg, BA Martin, ... Cancer research 78 (17), 5144-5154, 2018 | 189 | 2018 |
Successful translation of fluorescence navigation during oncologic surgery: a consensus report EL Rosenthal, JM Warram, E De Boer, JP Basilion, MA Biel, M Bogyo, ... Journal of Nuclear Medicine 57 (1), 144-150, 2016 | 160 | 2016 |
Oncologic procedures amenable to fluorescence-guided surgery KE Tipirneni, JM Warram, LS Moore, AC Prince, E de Boer, AH Jani, ... Annals of surgery 266 (1), 36-47, 2017 | 155 | 2017 |
The status of contemporary image-guided modalities in oncologic surgery EL Rosenthal, JM Warram, KI Bland, KR Zinn Annals of surgery 261 (1), 46-55, 2015 | 150 | 2015 |
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers RW Gao, N Teraphongphom, E de Boer, NS van den Berg, V Divi, ... Theranostics 8 (9), 2488, 2018 | 145 | 2018 |
Antibody-based imaging strategies for cancer JM Warram, E De Boer, AG Sorace, TK Chung, H Kim, RG Pleijhuis, ... Cancer and Metastasis Reviews 33, 809-822, 2014 | 137 | 2014 |
Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer EL Rosenthal, LS Moore, K Tipirneni, E de Boer, TM Stevens, YE Hartman, ... Clinical Cancer Research 23 (16), 4744-4752, 2017 | 131 | 2017 |
A triple‐targeted ultrasound contrast agent provides improved localization to tumor vasculature JM Warram, AG Sorace, R Saini, HR Umphrey, KR Zinn, K Hoyt Journal of Ultrasound in Medicine 30 (7), 921-931, 2011 | 120 | 2011 |
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas E De Boer, JM Warram, MD Tucker, YE Hartman, LS Moore, JS De Jong, ... Scientific reports 5 (1), 10169, 2015 | 106 | 2015 |
Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer AG Sorace, JM Warram, H Umphrey, K Hoyt Journal of drug targeting 20 (1), 43-54, 2012 | 102 | 2012 |
Regulatory aspects of optical methods and exogenous targets for cancer detection WS Tummers, JM Warram, KE Tipirneni, J Fengler, P Jacobs, L Shankar, ... Cancer research 77 (9), 2197-2206, 2017 | 86 | 2017 |
IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques KR Zinn, M Korb, S Samuel, JM Warram, D Dion, C Killingsworth, J Fan, ... Molecular imaging and biology 17, 49-57, 2015 | 78 | 2015 |
Surgical margins in oral cavity squamous cell carcinoma: current practices and future directions JJ Kain, AC Birkeland, N Udayakumar, AB Morlandt, TM Stevens, ... The Laryngoscope 130 (1), 128-138, 2020 | 77 | 2020 |
Consensus conference statement on the general use of near-infrared fluorescence imaging and indocyanine green guided surgery: results of a modified Delphi study F Dip, L Boni, M Bouvet, T Carus, M Diana, J Falco, GC Gurtner, ... Annals of Surgery 275 (4), 685-691, 2022 | 74 | 2022 |
Breast Tumor Xenografts: Diffusion-weighted MR Imaging to Assess Early Therapy with Novel Apoptosis-Inducing Anti-DR5 Antibody1 H Kim, DE Morgan, H Zeng, WE Grizzle, JM Warram, CR Stockard, ... Radiology 248 (3), 844-851, 2008 | 70 | 2008 |
Fluorescence imaging of nerves during surgery EM Walsh, D Cole, KE Tipirneni, KI Bland, N Udayakumar, BB Kasten, ... Annals of surgery 270 (1), 69-76, 2019 | 69 | 2019 |
Recommendations for reporting on emerging optical imaging agents to promote clinical approval WS Tummers, JM Warram, NS van den Berg, SE Miller, RJ Swijnenburg, ... Theranostics 8 (19), 5336, 2018 | 68 | 2018 |
Determination of Breast Cancer Response to Bevacizumab Therapy Using Contrast‐Enhanced Ultrasound and Artificial Neural Networks K Hoyt, JM Warram, H Umphrey, L Belt, ME Lockhart, ML Robbin, KR Zinn Journal of Ultrasound in Medicine 29 (4), 577-585, 2010 | 66 | 2010 |